Jesús María
Hernández Rivas
Catedrático de Universidad
University of Paris-Sorbonne
París, FranciaUniversity of Paris-Sorbonne-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2023
-
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
The Lancet, Vol. 401, Núm. 10373, pp. 269-280